Supercritical	O
processed	O
starch	B:C0038179
nanosponge	O
as	O
a	O
carrier	O
for	O
enhancement	O
of	O
dissolution	O
and	O
pharmacological	O
efficacy	O
of	O
fenofibrate	O
.	O

Supercritical	O
processed	O
starch	O
nanosponge	B:C0005479
as	O
a	O
carrier	O
for	O
enhancement	O
of	O
dissolution	O
and	O
pharmacological	O
efficacy	O
of	O
fenofibrate	O
.	O

Supercritical	O
processed	O
starch	O
nanosponge	O
as	O
a	O
carrier	B:C0013161
for	O
enhancement	O
of	O
dissolution	O
and	O
pharmacological	O
efficacy	O
of	O
fenofibrate	O
.	O

Supercritical	O
processed	O
starch	O
nanosponge	O
as	O
a	O
carrier	O
for	O
enhancement	O
of	O
dissolution	B:C3830465
and	O
pharmacological	O
efficacy	O
of	O
fenofibrate	O
.	O

Supercritical	O
processed	O
starch	O
nanosponge	O
as	O
a	O
carrier	O
for	O
enhancement	O
of	O
dissolution	O
and	O
pharmacological	O
efficacy	O
of	O
fenofibrate	B:C0033228
.	O

In	O
current	O
study	B:C2603343
,	O
supercritical	O
processed	O
starch	O
nanosponge	O
(	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	O
for	O
poorly	O
water	O
soluble	O
drug	O
(	O
fenofibrate	O
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	O
-vivo	I:C1515655
performance	O
.	O

In	O
current	O
study	O
,	O
supercritical	O
processed	O
starch	B:C0038179
nanosponge	O
(	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	O
for	O
poorly	O
water	O
soluble	O
drug	O
(	O
fenofibrate	O
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	O
-vivo	I:C1515655
performance	O
.	O

In	O
current	O
study	O
,	O
supercritical	O
processed	O
starch	O
nanosponge	B:C0005479
(	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	O
for	O
poorly	O
water	O
soluble	O
drug	O
(	O
fenofibrate	O
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	O
-vivo	I:C1515655
performance	O
.	O

In	O
current	O
study	O
,	O
supercritical	O
processed	O
starch	O
nanosponge	O
(	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	O
for	O
poorly	O
water	O
soluble	O
drug	O
(	O
fenofibrate	O
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	O
-vivo	I:C1515655
performance	O
.	O

In	O
current	O
study	O
,	O
supercritical	O
processed	O
starch	O
nanosponge	O
(	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	B:C0013161
for	O
poorly	O
water	O
soluble	O
drug	O
(	O
fenofibrate	O
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	O
-vivo	I:C1515655
performance	O
.	O

In	O
current	O
study	O
,	O
supercritical	O
processed	O
starch	O
nanosponge	O
(	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	O
for	O
poorly	O
water	B:C0043047
soluble	O
drug	O
(	O
fenofibrate	O
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	O
-vivo	I:C1515655
performance	O
.	O

In	O
current	O
study	O
,	O
supercritical	O
processed	O
starch	O
nanosponge	O
(	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	O
for	O
poorly	O
water	O
soluble	O
drug	B:C0013227
(	O
fenofibrate	O
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	O
-vivo	I:C1515655
performance	O
.	O

In	O
current	O
study	O
,	O
supercritical	O
processed	O
starch	O
nanosponge	O
(	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	O
for	O
poorly	O
water	O
soluble	O
drug	O
(	O
fenofibrate	B:C0033228
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	O
-vivo	I:C1515655
performance	O
.	O

In	O
current	O
study	O
,	O
supercritical	O
processed	O
starch	O
nanosponge	O
(	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
)	O
used	O
as	O
a	O
carrier	O
for	O
poorly	O
water	O
soluble	O
drug	O
(	O
fenofibrate	O
)	O
to	O
enhance	O
its	O
in	O
-	O
vitro	O
and	O
in	B:C1515655
-vivo	I:C1515655
performance	O
.	O

supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
was	O
prepared	O
by	O
using	O
sol-	O
gel	I:C0201683
method	I:C0201683
and	O
effective	O
supercritical	O
drying	I:C3830390
technique	I:C3830390
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
was	O
prepared	O
by	O
using	O
sol-	B:C0201683
gel	I:C0201683
method	I:C0201683
and	O
effective	O
supercritical	O
drying	I:C3830390
technique	I:C3830390
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
was	O
prepared	O
by	O
using	O
sol-	O
gel	I:C0201683
method	I:C0201683
and	O
effective	O
supercritical	B:C3830390
drying	I:C3830390
technique	I:C3830390
.	O

Fenofibrate	B:C0033228
was	O
loaded	O
into	O
the	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
by	O
using	O
solvent	O
immersion	I:C0201683
method	I:C0201683
with	O
selected	O
and	O
optimized	O
organic	O
solvent	I:C0360100
.	O

Fenofibrate	O
was	O
loaded	O
into	O
the	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
by	O
using	O
solvent	O
immersion	I:C0201683
method	I:C0201683
with	O
selected	O
and	O
optimized	O
organic	O
solvent	I:C0360100
.	O

Fenofibrate	O
was	O
loaded	O
into	O
the	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
by	O
using	O
solvent	B:C0201683
immersion	I:C0201683
method	I:C0201683
with	O
selected	O
and	O
optimized	O
organic	O
solvent	I:C0360100
.	O

Fenofibrate	O
was	O
loaded	O
into	O
the	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
by	O
using	O
solvent	O
immersion	I:C0201683
method	I:C0201683
with	O
selected	O
and	O
optimized	O
organic	B:C0360100
solvent	I:C0360100
.	O

BET	O
surface	O
area	O
of	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
was	O
evaluated	O
by	O
nitrogen	O
adsorption	I:C0022885
/	I:C0022885
desorption	I:C0022885
analysis	I:C0022885
.	O

BET	O
surface	O
area	O
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
was	O
evaluated	B:C0220825
by	O
nitrogen	O
adsorption	I:C0022885
/	I:C0022885
desorption	I:C0022885
analysis	I:C0022885
.	O

BET	O
surface	O
area	O
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
was	O
evaluated	O
by	O
nitrogen	B:C0022885
adsorption	I:C0022885
/	I:C0022885
desorption	I:C0022885
analysis	I:C0022885
.	O

supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	O
,	O
FTIR	O
,	O
SEM	O
,	O
Contact	O
angle	O
study	O
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	B:C0013227
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	O
,	O
FTIR	O
,	O
SEM	O
,	O
Contact	O
angle	O
study	O
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	O
,	O
FTIR	O
,	O
SEM	O
,	O
Contact	O
angle	O
study	O
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	B:C0006780
,	O
XRPD	O
,	O
FTIR	O
,	O
SEM	O
,	O
Contact	O
angle	O
study	O
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	B:C1135961
,	O
FTIR	O
,	O
SEM	O
,	O
Contact	O
angle	O
study	O
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	O
,	O
FTIR	B:C0206055
,	O
SEM	O
,	O
Contact	O
angle	O
study	O
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	O
,	O
FTIR	O
,	O
SEM	B:C0026020
,	O
Contact	O
angle	O
study	O
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	O
,	O
FTIR	O
,	O
SEM	O
,	O
Contact	O
angle	O
study	B:C2603343
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	O
,	O
FTIR	O
,	O
SEM	O
,	O
Contact	O
angle	O
study	O
and	O
evaluated	B:C0220825
for	O
in	O
-	O
vitro	O
,	O
in	O
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
and	O
drug	O
loaded	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
were	O
characterized	O
by	O
DSC	O
,	O
XRPD	O
,	O
FTIR	O
,	O
SEM	O
,	O
Contact	O
angle	O
study	O
and	O
evaluated	O
for	O
in	O
-	O
vitro	O
,	O
in	B:C1515655
-	I:C1515655
vivo	I:C1515655
studies	O
.	O

The	O
results	O
revealed	O
that	O
the	O
formed	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
material	O
has	O
high	O
surface	O
area	O
(	O
180	O
m2	O
/	O
gm	O
)	O
with	O
pore	O
size	O
(	O
40	O
nm	O
to	O
200	O
nm	O
)	O
.	O

The	O
DSC	B:C0006780
and	O
XRPD	O
study	O
revealed	O
the	O
amorphization	O
of	O
drug	O
within	O
a	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

The	O
DSC	O
and	O
XRPD	B:C1135961
study	O
revealed	O
the	O
amorphization	O
of	O
drug	O
within	O
a	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

The	O
DSC	O
and	O
XRPD	O
study	B:C2603343
revealed	O
the	O
amorphization	O
of	O
drug	O
within	O
a	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

The	O
DSC	O
and	O
XRPD	O
study	O
revealed	O
the	O
amorphization	O
of	O
drug	B:C0013227
within	O
a	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

The	O
DSC	O
and	O
XRPD	O
study	O
revealed	O
the	O
amorphization	O
of	O
drug	O
within	O
a	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

SEM	B:C0026020
study	O
showed	O
the	O
continuous	O
porous	O
structure	I:C0678594
with	O
differ	O
nanosized	O
pores	I:C1881977
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

SEM	O
study	B:C2603343
showed	O
the	O
continuous	O
porous	O
structure	I:C0678594
with	O
differ	O
nanosized	O
pores	I:C1881977
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

SEM	O
study	O
showed	O
the	O
continuous	O
porous	B:C0678594
structure	I:C0678594
with	O
differ	O
nanosized	O
pores	I:C1881977
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

SEM	O
study	O
showed	O
the	O
continuous	O
porous	O
structure	I:C0678594
with	O
differ	O
nanosized	B:C1881977
pores	I:C1881977
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

SEM	O
study	O
showed	O
the	O
continuous	O
porous	O
structure	I:C0678594
with	O
differ	O
nanosized	O
pores	I:C1881977
of	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

Contact	O
angle	O
study	B:C2603343
showed	O
improvement	O
in	O
aqueous	O
wetting	O
property	O
of	O
drug	O
within	O
a	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

Contact	O
angle	O
study	O
showed	O
improvement	O
in	O
aqueous	O
wetting	O
property	O
of	O
drug	B:C0013227
within	O
a	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

Contact	O
angle	O
study	O
showed	O
improvement	O
in	O
aqueous	O
wetting	O
property	O
of	O
drug	O
within	O
a	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
.	O

In	O
-	O
vitro	O
drug	O
release	O
study	B:C2603343
showed	O
remarkable	O
dissolution	O
enhancement	O
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
formulation	O
as	O
compared	O
to	O
plain	O
drug	O
.	O

In	O
-	O
vitro	O
drug	O
release	O
study	O
showed	O
remarkable	O
dissolution	B:C3830465
enhancement	O
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
formulation	O
as	O
compared	O
to	O
plain	O
drug	O
.	O

In	O
-	O
vitro	O
drug	O
release	O
study	O
showed	O
remarkable	O
dissolution	O
enhancement	O
of	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
formulation	O
as	O
compared	O
to	O
plain	O
drug	O
.	O

In	O
-	O
vitro	O
drug	O
release	O
study	O
showed	O
remarkable	O
dissolution	O
enhancement	O
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
formulation	B:C0524527
as	O
compared	O
to	O
plain	O
drug	O
.	O

In	O
-	O
vitro	O
drug	O
release	O
study	O
showed	O
remarkable	O
dissolution	O
enhancement	O
of	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
formulation	O
as	O
compared	O
to	O
plain	O
drug	B:C0013227
.	O

In	B:C1515655
vivo	I:C1515655
pharmacodynamic	O
study	I:C1709518
(	O
hyperlipidaemia	O
model	O
)	O
showed	O
SNSS	O
based	O
formulation	O
significantly	O
improved	O
the	O
bioavailability	O
of	O
drug	O
.	O

In	O
vivo	I:C1515655
pharmacodynamic	B:C1709518
study	I:C1709518
(	O
hyperlipidaemia	O
model	O
)	O
showed	O
SNSS	O
based	O
formulation	O
significantly	O
improved	O
the	O
bioavailability	O
of	O
drug	O
.	O

In	O
vivo	I:C1515655
pharmacodynamic	O
study	I:C1709518
(	O
hyperlipidaemia	B:C0020473
model	O
)	O
showed	O
SNSS	O
based	O
formulation	O
significantly	O
improved	O
the	O
bioavailability	O
of	O
drug	O
.	O

In	O
vivo	I:C1515655
pharmacodynamic	O
study	I:C1709518
(	O
hyperlipidaemia	O
model	O
)	O
showed	O
SNSS	B:C0005479
based	O
formulation	O
significantly	O
improved	O
the	O
bioavailability	O
of	O
drug	O
.	O

In	O
vivo	I:C1515655
pharmacodynamic	O
study	I:C1709518
(	O
hyperlipidaemia	O
model	O
)	O
showed	O
SNSS	O
based	O
formulation	B:C0524527
significantly	O
improved	O
the	O
bioavailability	O
of	O
drug	O
.	O

In	O
vivo	I:C1515655
pharmacodynamic	O
study	I:C1709518
(	O
hyperlipidaemia	O
model	O
)	O
showed	O
SNSS	O
based	O
formulation	O
significantly	O
improved	B:C0184511
the	O
bioavailability	O
of	O
drug	O
.	O

In	O
vivo	I:C1515655
pharmacodynamic	O
study	I:C1709518
(	O
hyperlipidaemia	O
model	O
)	O
showed	O
SNSS	O
based	O
formulation	O
significantly	O
improved	O
the	O
bioavailability	O
of	O
drug	B:C0013227
.	O

Thus	O
supercritical	B:C0005479
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
carrier	O
system	O
has	O
good	O
potential	O
to	O
be	O
explored	O
as	O
a	O
delivery	O
system	I:C0085104
for	O
poorly	O
water	O
soluble	O
drugs	O
.	O

Thus	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
carrier	B:C0013161
system	O
has	O
good	O
potential	O
to	O
be	O
explored	O
as	O
a	O
delivery	O
system	I:C0085104
for	O
poorly	O
water	O
soluble	O
drugs	O
.	O

Thus	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
carrier	O
system	O
has	O
good	O
potential	O
to	O
be	O
explored	O
as	O
a	O
delivery	B:C0085104
system	I:C0085104
for	O
poorly	O
water	O
soluble	O
drugs	O
.	O

Thus	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
carrier	O
system	O
has	O
good	O
potential	O
to	O
be	O
explored	O
as	O
a	O
delivery	O
system	I:C0085104
for	O
poorly	O
water	B:C0043047
soluble	O
drugs	O
.	O

Thus	O
supercritical	O
processed	I:C0005479
starch	I:C0005479
nanosponge	I:C0005479
carrier	O
system	O
has	O
good	O
potential	O
to	O
be	O
explored	O
as	O
a	O
delivery	O
system	I:C0085104
for	O
poorly	O
water	O
soluble	O
drugs	B:C0013227
.	O

